SEC Form 4 · accession 0001636178-26-000026
UNITED THERAPEUTICS Corp · UTHR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James Edgemond
Officer — CFO AND TREASURER
Period of report
Jun 11, 2026
Accepted (ET)
Jun 12, 2026 · 5:26 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001082554
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 11, 2026 | M | 10,000 | $117.76 | A | 28,876 | D | |
| Common StockF2 | Jun 11, 2026 | S | 46 | $542.9374 | D | 28,830 | D | |
| Common StockF3 | Jun 11, 2026 | S | 154 | $544.369 | D | 28,676 | D | |
| Common StockF4 | Jun 11, 2026 | S | 442 | $545.1386 | D | 28,234 | D | |
| Common StockF5 | Jun 11, 2026 | S | 134 | $547.0788 | D | 28,100 | D | |
| Common StockF6 | Jun 11, 2026 | S | 2,037 | $548.0179 | D | 26,063 | D | |
| Common StockF7 | Jun 11, 2026 | S | 1,974 | $549.1055 | D | 24,089 | D | |
| Common StockF8 | Jun 11, 2026 | S | 3,333 | $550.0399 | D | 20,756 | D | |
| Common StockF9 | Jun 11, 2026 | S | 1,560 | $551.0977 | D | 19,196 | D | |
| Common StockF10 | Jun 11, 2026 | S | 320 | $551.825 | D | 18,876 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option | $117.76 | Jun 11, 2026 | M | 10,000 | D | Mar 15, 2023 | Mar 15, 2027 | Common Stock | 10,000 | 10,000 | D |
Explanation of responses
- F1This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025.
- F10This transaction was executed in multiple trades at prices ranging from $551.62 to $552.03. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F2This transaction was executed in multiple trades at prices ranging from $542.02 to $543.01. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F3This transaction was executed in multiple trades at prices ranging from $543.76 to $544.49. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F4This transaction was executed in multiple trades at prices ranging from $544.80 to $545.67. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F5This transaction was executed in multiple trades at prices ranging from $546.60 to $547.55. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F6This transaction was executed in multiple trades at prices ranging from $547.60 to $548.59. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F7This transaction was executed in multiple trades at prices ranging from $548.60 to $549.59. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F8This transaction was executed in multiple trades at prices ranging from $549.61 to $550.59. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F9This transaction was executed in multiple trades at prices ranging from $550.62 to $551.51. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.